| Company/Division name | Lonza |
| Parent company | Lonza Group AG |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Houston |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | AdCOVID single-dose intranasal Covid-19 vaccine |
| What domestic positive factors made reshoring more attractive? | Lead time/Time to market, Skilled workforce availability/training, Under-utilized capacity, Other, Covid-19 |
